TW358094B - Piperazinedione derivatives, their preparation and their use as moduators of multi-drug resistance - Google Patents
Piperazinedione derivatives, their preparation and their use as moduators of multi-drug resistanceInfo
- Publication number
- TW358094B TW358094B TW084113836A TW84113836A TW358094B TW 358094 B TW358094 B TW 358094B TW 084113836 A TW084113836 A TW 084113836A TW 84113836 A TW84113836 A TW 84113836A TW 358094 B TW358094 B TW 358094B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- alkyl
- nco2r11
- unsubstituted
- nhco
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9426224.3A GB9426224D0 (en) | 1994-12-23 | 1994-12-23 | Pharmaceutical compounds |
| ZA9510909A ZA9510909B (en) | 1994-12-23 | 1995-12-21 | Pharmaceutical compounds |
| IL11652595A IL116525A0 (en) | 1994-12-23 | 1995-12-22 | Piperazinedione derivatives their preparation and use |
| PCT/GB1995/003027 WO1996020190A1 (en) | 1994-12-23 | 1995-12-22 | Piperazine 2,5 dione derivatives as modulators of multi-drug resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW358094B true TW358094B (en) | 1999-05-11 |
Family
ID=10766589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW084113836A TW358094B (en) | 1994-12-23 | 1995-12-23 | Piperazinedione derivatives, their preparation and their use as moduators of multi-drug resistance |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0799222A1 (zh) |
| JP (1) | JPH10511384A (zh) |
| CN (1) | CN1175253A (zh) |
| AU (1) | AU698828B2 (zh) |
| BG (1) | BG101602A (zh) |
| BR (1) | BR9510410A (zh) |
| CA (1) | CA2207500A1 (zh) |
| CZ (1) | CZ190097A3 (zh) |
| FI (1) | FI972660A (zh) |
| GB (1) | GB9426224D0 (zh) |
| HU (1) | HUT77943A (zh) |
| IL (1) | IL116525A0 (zh) |
| NO (1) | NO972937L (zh) |
| NZ (1) | NZ297847A (zh) |
| PL (1) | PL320916A1 (zh) |
| SK (1) | SK83697A3 (zh) |
| TW (1) | TW358094B (zh) |
| WO (1) | WO1996020190A1 (zh) |
| ZA (1) | ZA9510909B (zh) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA979329B (en) * | 1996-10-18 | 1999-04-19 | Xenova Ltd | Pharmaceutical compounds |
| GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| CA2346689A1 (en) | 1998-10-08 | 2000-04-20 | Gregor James Macdonald | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| IL150430A0 (en) * | 2000-01-18 | 2002-12-01 | Nereus Pharmaceuticals Inc | Cell division inhibitors and process for producing the same |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| US7935704B2 (en) | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| IL166628A0 (en) | 2002-08-02 | 2006-01-15 | Nereus Pharmaceuticals Inc | Dehydrophenyl lahistins and analogs thereof and the synthesis of dehydrophenyllahistins and analogs thereof |
| US8129527B2 (en) | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| CN103396372B (zh) * | 2013-08-09 | 2015-05-20 | 中国科学院南海海洋研究所 | 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用 |
| US10076518B2 (en) | 2015-03-06 | 2018-09-18 | Beyondspring Pharmaceuticals, Inc. | Method of treating a brain tumor |
| US10238650B2 (en) | 2015-03-06 | 2019-03-26 | Beyondspring Pharmaceuticals, Inc. | Method of treating cancer associated with a RAS mutation |
| MX2018000451A (es) | 2015-07-13 | 2018-05-07 | Beyondspring Pharmaceuticals Inc | Composiciones de plinabulina. |
| RU2753543C1 (ru) | 2016-02-08 | 2021-08-17 | Бейондспринг Фармасьютикалс, Инк. | Композиции, содержащие тукаресол или его аналоги |
| WO2017214052A1 (en) | 2016-06-06 | 2017-12-14 | Beyondspring Pharmaceuticals, Inc. | Composition and method for reducing neutropenia |
| WO2018129381A1 (en) | 2017-01-06 | 2018-07-12 | Beyondspring Pharmaceuticals, Inc. | Tubulin binding compounds and therapeutic use thereof |
| JP2020514412A (ja) | 2017-02-01 | 2020-05-21 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | 好中球減少症の低減方法 |
| KR20200112881A (ko) | 2018-01-24 | 2020-10-05 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0649410B1 (en) * | 1992-07-10 | 1997-05-02 | Laboratoires Glaxo Sa | Anilide derivatives |
| GB9217331D0 (en) * | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
-
1994
- 1994-12-23 GB GBGB9426224.3A patent/GB9426224D0/en active Pending
-
1995
- 1995-12-21 ZA ZA9510909A patent/ZA9510909B/xx unknown
- 1995-12-22 WO PCT/GB1995/003027 patent/WO1996020190A1/en not_active Application Discontinuation
- 1995-12-22 CN CN95197672A patent/CN1175253A/zh active Pending
- 1995-12-22 PL PL95320916A patent/PL320916A1/xx unknown
- 1995-12-22 CZ CZ971900A patent/CZ190097A3/cs unknown
- 1995-12-22 AU AU43100/96A patent/AU698828B2/en not_active Ceased
- 1995-12-22 SK SK836-97A patent/SK83697A3/sk unknown
- 1995-12-22 NZ NZ297847A patent/NZ297847A/en unknown
- 1995-12-22 JP JP8520301A patent/JPH10511384A/ja active Pending
- 1995-12-22 IL IL11652595A patent/IL116525A0/xx unknown
- 1995-12-22 BR BR9510410-0A patent/BR9510410A/pt not_active Application Discontinuation
- 1995-12-22 CA CA002207500A patent/CA2207500A1/en not_active Abandoned
- 1995-12-22 HU HU9800398A patent/HUT77943A/hu unknown
- 1995-12-22 EP EP95941797A patent/EP0799222A1/en not_active Withdrawn
- 1995-12-23 TW TW084113836A patent/TW358094B/zh active
-
1997
- 1997-06-11 BG BG101602A patent/BG101602A/xx unknown
- 1997-06-19 FI FI972660A patent/FI972660A/fi unknown
- 1997-06-23 NO NO972937A patent/NO972937L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL116525A0 (en) | 1996-03-31 |
| WO1996020190A1 (en) | 1996-07-04 |
| BG101602A (en) | 1998-02-27 |
| ZA9510909B (en) | 1996-08-30 |
| AU4310096A (en) | 1996-07-19 |
| FI972660A0 (fi) | 1997-06-19 |
| NO972937D0 (no) | 1997-06-23 |
| NO972937L (no) | 1997-06-23 |
| GB9426224D0 (en) | 1995-02-22 |
| AU698828B2 (en) | 1998-11-05 |
| EP0799222A1 (en) | 1997-10-08 |
| HUT77943A (hu) | 1998-12-28 |
| CA2207500A1 (en) | 1996-07-04 |
| JPH10511384A (ja) | 1998-11-04 |
| PL320916A1 (en) | 1997-11-10 |
| SK83697A3 (en) | 1998-05-06 |
| CZ190097A3 (cs) | 1998-01-14 |
| BR9510410A (pt) | 1999-09-08 |
| NZ297847A (en) | 1999-04-29 |
| FI972660A (fi) | 1997-08-22 |
| CN1175253A (zh) | 1998-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW358094B (en) | Piperazinedione derivatives, their preparation and their use as moduators of multi-drug resistance | |
| TW370450B (en) | Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives | |
| TW334427B (en) | Preparation for diketopiperazines use as inhibitors of plasminogen activator inhibitor | |
| MY104376A (en) | N-imidazolyl deravatives of bicyclic compounds and process for their preparation. | |
| NZ330656A (en) | Tricyclic compounds, their production and use | |
| EP0316022A3 (en) | Tricyclic compounds | |
| ES2121441T3 (es) | Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco | |
| MXPA02001473A (es) | Azaindoles que tienen afinidad con el receptor de serotonina. | |
| CA2030397A1 (en) | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders | |
| NO990335L (no) | Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling | |
| NO973213L (no) | Nye 2-(1H)-quinolinforbindelser, fremgangsmåter ved fremstilling av slike samt farmasöytiske sammensetninger omfattende disse | |
| AU7733491A (en) | Isochromane derivatives | |
| ATE133672T1 (de) | Thienopyridin-derivate, deren herstellung und verwendung | |
| WO2006085048A3 (en) | Pro-fragrance and pro-flavorant compositions | |
| MXPA04001171A (es) | Compuestos policiclicos condensados. | |
| DE3468104D1 (en) | New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use | |
| AU4726089A (en) | Benzoxazepine derivative | |
| CA2187541A1 (en) | Benzoxazepine derivatives, salts thereof, and drugs containing the same | |
| GB1455356A (en) | Imidazotriazines | |
| JPS5246095A (en) | Preparation of novel thienopyrimidine derivatives | |
| JPS55120575A (en) | Cis-2,3-epoxy-4-lower alkoxyphenylbutanoic acid derivative and its production | |
| IL92646A0 (en) | Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| WO2002072540A3 (en) | Improved methods of ortho alkylation | |
| IE56365B1 (en) | Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives | |
| GB2311781A (en) | Piperazine 2,5 dione derivatives as modulators of multi-drug resistance |